Evommune receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evommune Inc (EVMN)
Track the Evommune share price today and view real-time EVMN share price data, including charts, technicals, and key financials. View the EVMN premarket stock price ahead of the market session or assess the after hours quote. Explore EVMN stock price movements, trading volume, and market activity across the NYSE exchange.
What Is the Evommune Stock Price Today?
The Evommune stock price today is 12.82.
What Is the Stock Symbol for Evommune?
The stock symbol for Evommune is ""EVMN.""
What Stock Exchange Does Evommune Trade On?
Evommune is listed and trades on the NYSE stock exchange.
Is Evommune a Good Stock to Buy?
Determining whether Evommune or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVMN quote. (ISIN: US30054Y1073)
What Is the Evommune Stock Price Today?
The Evommune stock price today is 12.82.
What Is the Stock Symbol for Evommune?
The stock symbol for Evommune is ""EVMN.""
What Stock Exchange Does Evommune Trade On?
Evommune is listed and trades on the NYSE stock exchange.
Is Evommune a Good Stock to Buy?
Determining whether Evommune or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVMN quote. (ISIN: US30054Y1073)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.65
13.82
52 wk Range
12.65
33.20
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.6513.82
52 wk Range
12.6533.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EVMN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
35.86
Upside
+179.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Evommune receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evommune receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 35.86
(+179.70% Upside)
Earnings
Latest Release
08/05/2026
EPS / Forecast
-0.64 / -0.76
Revenue / Forecast
-- / --
Compare EVMN to Peers and Sector
Metrics to compare | EVMN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVMNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | 5.8x | −0.4x | |
PEG Ratio | −0.07 | 0.55 | 0.00 | |
Price/Book | 1.5x | 1.8x | 2.6x | |
Price / LTM Sales | 46.2x | 6.5x | 3.0x | |
Upside (Analyst Target) | 134.0% | 199.4% | 51.3% | |
Fair Value Upside | Unlock | −8.6% | 7.3% | Unlock |
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Evommune (EVMN) Stock Price Today?
The Evommune stock price today is 12.82 USD.
What Stock Exchange Does Evommune Trade On?
Evommune is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Evommune?
The stock symbol for Evommune is "EVMN."
What Is the Evommune Market Cap?
As of today, Evommune market cap is 461.76M USD.
What Is Evommune's Earnings Per Share (TTM)?
The Evommune EPS (TTM) is -5.36.
When Is the Next Evommune Earnings Date?
Evommune will release its next earnings report on 02/09/2026.
From a Technical Analysis Perspective, Is EVMN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Evommune Stock Split?
Evommune has split 0 times.
How Many Employees Does Evommune Have?
Evommune has 48 employees.
What is the current trading status of Evommune (EVMN)?
As of 02/07/2026, Evommune (EVMN) is trading at a price of 12.82 USD, with a previous close of 12.82 USD. The stock has fluctuated within a day range of 12.65 USD to 13.82 USD, while its 52-week range spans from 12.65 USD to 33.20 USD.
What Is Evommune (EVMN) Price Target According to Analysts?
The average 12-month price target for Evommune is 35.86 USD, with a high estimate of 55 USD and a low estimate of 26 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +179.70% Upside potential.
What Is the EVMN Premarket Price?
EVMN's last pre-market stock price is 13.20 USD. The pre-market share volume is 5,620.00, and the stock has decreased by -0.09, or -0.68%.
What Is the EVMN After Hours Price?
EVMN's last after hours stock price is 13.17 USD, the stock has decreased by 0.35, or 2.73%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.